Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.73 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.70 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.70 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.62 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.54 |
| ▸ | TLR2 | O60603 | 3/20 | 0.51 |
| ▸ | LPAR5 | Q9H1C0 | 6/20 | 0.49 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.49 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.49 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.48 |
| ▸ | AKT1 | P31749 | 2/20 | 0.46 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.46 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.46 |
| ▸ | AKT2 | P31751 | 1/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.46 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.46 |
| ▸ | GAB1 | Q13480 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29133994 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL28622692 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL29206151 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL28622690 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL23300849 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL25394384 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL931685 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL21568785 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL22092476 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL29692534 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168746-B2 | Biomimetic materials for protein storage and transport | UCHICAGO ARGONNE, LLC (US) | 2012-05-01 | — | — | US | claimed |
| EP-1075276-B1 | ADJUVANT COMPOSITION AND METHODS FOR ITS USE | CORIXA CORP (US) | 2007-10-17 | — | — | EP | claimed |
| EP-4694867-A2 | LIPID NANOPARTICLES FOR DELIVERY OF AGENTS | Massachusetts Institute of Technology (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| EP-4328309-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-20250049713-A1 | LIPID NANOPARTICLES FOR DELIVERY OF AGENTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-02-13 | — | — | US | disclosed |
| WO-2024216171-A2 | LIPID NANOPARTICLES FOR DELIVERY OF AGENTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-10-17 | — | — | WO | disclosed |
| EP-4328309-A2 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-4059505-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2024-02-21 | — | — | EP | disclosed |
| EP-3981435-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2023-08-16 | — | — | EP | disclosed |
| EP-4059505-A1 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2022-09-21 | — | — | EP | disclosed |
| US-20220273817-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| CN-114728016-A | Lipid composition | 富士胶片株式会社 | 2022-07-08 | — | — | CN | disclosed |
| EP-3981435-A1 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2022-04-13 | — | — | EP | disclosed |
| US-20220096381-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-03-31 | — | — | US | disclosed |
| CN-113924128-A | Lipid composition | 富士胶片株式会社 | 2022-01-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049713-A1 | LIPID NANOPARTICLES FOR DELIVERY OF AGENTS | FABP3, LIPC, PHOSPHO1 | PLA2G2C 285/4885LPAR1 32/4885LPAR3 20/4885 |
| US-20220273817-A1 | LIPID COMPOSITION | NR1H3, NR1H2, NR1H4 | PLA2G2C 1045/4885LPAR1 43/4885LPAR3 52/4885 |
| US-20220096381-A1 | LIPID COMPOSITION | NR1H3, NR1H4, NR1H2 | PLA2G2C 735/4885LPAR1 8/4885LPAR3 10/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | PLA2G2C 559/4885LPAR1 7/4885LPAR3 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.